Month: June 2020

ノースカロライナ州ローリー発, June 12, 2020 (GLOBE NEWSWIRE) — PRAヘルス･サイエンス (PRA Health Sciences, Inc.、NASDAQ: PRAH) は本日、商業用のHealth HarmonyにおけるCOVID-19モニタリングプログラム (COVID-19 Monitoring Program) について、Microsoft Healthcare Botサービスの統合による強化を発表した。COVID-19モニタリングプログラムに登録しているPRAのHealth Harmonyデジタルプラットフォームのユーザーは、COVID-19関連の質問を認識して応答できるAIベースのチャットボットを使用して、自身のCOVID-19ケアを強化できる。COVID-19チャットボットは、PRAのHealth Harmonyデジタルヘルスプラットフォーム内において一連の会話型の質問と対話を通じて、ユーザーの症状を米国疾病予防管理センターのガイダンスと比較し、3つの利用可能なCOVID-19プログラムの1つを推奨する。ユーザーはプログラムに登録する必要がある。Health Harmonyアプリのユーザーにとって、登録エクスペリエンスはよりパーソナライズされ、必要なCOVID-19ケアのレベルを決定する際の正確性が向上する。PRAのCOVID-19モニタリングプログラムを導入している組織の場合、この統合により、患者のフローを理解し、より機敏にケアをモニタリング、情報提供、個別化することができる。PRAヘルス･サイエンスのエグゼクティブ･バイス･プレジデント兼最高科学責任者であるケント･テールケ (Kent Thoelke) は、次のように述べている。「PRAは、マイクロソフト (Microsoft) のような最先端の企業と緊密に連携して、特に危機と不確実性の高い時期において、患者のニーズの変化に応じて、患者に革新的な新しいケアモデルを提供する独自の立場を築いています。PRAのHealth...

미국 노스캐롤라이나주 롤리, June 12, 2020 (GLOBE NEWSWIRE) — PRA 헬스사이언스(PRA Health Sciences) (NASDAQ: PRAH)는 자사의 코로나19 모니터링 상용 프로그램인 Health Harmony COVID-19 Monitoring Program에 Microsoft Healthcare Bot 서비스를 통합해 기능을 한층 확대한다고 밝혔다. 소속 의료기관에서 COVID-19 Monitoring Program을 도입해 PRA의 Health Harmony 디지털 플랫폼을 활용하고 있는 사용자는 앞으로 AI 기반 챗봇을 이용해 자체적인 코로나19 케어를 확장할 수 있게 된다. 이 챗봇은 코로나19 관련 질문을 인식하고 대답할 수 있다.다양한 대화용 질문과 대답들이 PRA의 Health Harmony 디지털 보건 플랫폼에 통합된 코로나19 챗봇은 사용자의 증상을 미국 질병통제예방센터 가이드라인과 대조한다. 그런 다음 코로나19 프로그램 3개 가운데 사용자가 도입해야 할 프로그램 하나를 추천하게 된다. Health Harmony 앱 사용자를 위해 프로그램 도입은 한층 개인화된 형태로 이루어지며 사용자에게 필요한 코로나19 케어 수준을 정확하게 결정한다. PRA의 COVID-19 Monitoring Program을 도입한 의료기관들은 환자 플로우를 이해한 뒤 보다 민첩한 형태로 모니터링, 교육, 개별 케어를 진행할 수 있다.PRA 헬스사이언스 부사장인 켄트 토엘케(Kent Thoelke) 최고과학책임자는 “마이크로소프트와 같은 첨단 기업과 긴밀한 협업을 진행하면서 PRA는 혁신적인 환자 케어 모델을 공급할 수 있게 됐다. 특히 요즘과 같이 위기와...

RALEIGH, N.C., June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) hari ini mengumumkan peningkatan Program Pemantauan COVID-19 Health Harmony miliknya dengan penyepaduan perkhidmatan Microsoft Healthcare Bot. Pengguna platform digital Health Harmony PRA yang mendaftar dalam Program Pemantauan COVID-19 organisasi mereka boleh menggunakan bot sembang berdasarkan AI, yang boleh mengenal pasti menjawab soalan yang berkaitan COVID-19, untuk meningkatkan penjagaan COVID-19 mereka sendiri.Melalui siri soalan perbualan dan interaksi dalam platform kesihatan digital Health Harmony PRA, bot sembang COVID-19 membandingkan simptom pengguna dengan panduan Pusat Kawalan Penyakit kemudian mengesyorkan salah satu daripada tiga program COVID-19 yang boleh mereka daftar. Untuk pengguna aplikasi Health Harmony, pengalaman pendaftaran...

NOTICE OF AGM AND POSTING OF ANNUAL REPORTDublin and London – June 12, 2020 –  Providence Resources P.l.c. (PVR LN, PRP ID), the Irish based Oil and Gas Energy Company, today is sending its Annual Report for the year ended December 31, 2019 (“Annual Report”) together with a notice of its Annual General Meeting (“AGM Notice”) to shareholders.  The Annual General Meeting is convened to be held at The Clayton Hotel Leopardstown, Sandyford Business District, Dublin D18 K2P1, Ireland, on Monday, July 20, 2020 at 11.00am.   Copies of the Annual Report and the AGM Notice will shortly be available on the Company’s website at www.providenceresources.com.COVID-19Shareholders are requested not to attend the General meeting in person but instead avail of the proxy voting service. A facility will be provided for shareholders...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICESVANCOUVER, British Columbia, June 12, 2020 (GLOBE NEWSWIRE) — Thor Explorations Ltd. (TSXV: THX) (“Thor” or the “Company”) announces that it intends to raise up to approximately US$10 million and in cooperation with certain shareholders place up to approximately US$5 million of previously issued stock via a best efforts brokered private placement.The private placement will consist of up to 40 million units with each unit comprising up to 2 common shares issued from Treasury at a price of C$0.18 per share (for up to 80 million common shares) (“Treasury Offering”) and up to 1 previously issued common share (for up to 40 million common shares) issued at a price of C$0.16 per share (“Secondary Sale”).The Private Placement will be co-led by H & P...

Second Quarter Fiscal 2020 Highlights (All comparisons year-over-year unless otherwise noted)Revenues of $18.9 million, an increase of 105%, compared to $9.2 millionLoss from operations improved to $(8.1) million compared to $(17.6) millionNet loss decreased to $(14.8) million compared to $(19.5) millionAdjusted EBITDA of $(3.3) million compared to $(14.5) millionGross profit of $0.2 million (0.9% gross margin) compared to gross loss of $(3.6) million ((39.5)% gross margin)Operating expense of $8.3 million, a decrease of $5.7 million, or 41%Backlog of $1.34 billion, an increase of $80.8 million, or 6%DANBURY, Conn., June 12, 2020 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in fuel cell technology — with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable...

 Transaction Introduces Tattooed Chef as Publicly Listed CompanyConference call to be held today at 8:00 a.m. EDTParamount, California and Delray Beach, Florida, June 12, 2020 (GLOBE NEWSWIRE) — Ittella International (the “Company”), a plant-based food company with a broad portfolio of innovative products available both in private label and the Company’s “Tattooed Chef” brand, and Forum Merger II Corporation (Nasdaq: FMCI) (“Forum”), a special purpose acquisition company, today announced a definitive agreement (the “Business Combination Agreement”) to combine the Company and Forum as Tattooed Chef, Inc. (“Tattooed Chef”). This transaction will introduce Tattooed Chef as a Nasdaq-listed public company, with an anticipated initial enterprise value of approximately $482 million, 2.2x Tattooed Chef’s estimated 2021 revenue of $222 million,...

StarStone U.S. mit vorteilhafter Position für künftigen Marktführerstatus auf den Märkten für Spezialimmobilien- und UnfallversicherungenJeff Consolino wird zum CEO und Ed Noonan zum Executive Chairman ernanntInvestitionen von Dragoneer, SkyKnight und Aquiline ermöglichen neue Kapazitäten auf den Märkten für Spezialimmobilien- und Unfallversicherungen, einschließlich Surplus-Lines-Versicherungen für ImmobilienHAMILTON, Bermuda, June 12, 2020 (GLOBE NEWSWIRE) — Enstar Group Limited (NASDAQ:ESGR) („Enstar“) hat heute bekanntgegeben, dass es eine Rekapitalisierung der StarStone U.S. Holdings, Inc. („StarStone U.S.“ oder „das Unternehmen“) unter der Leitung von SkyKnight Capital, L.P. („SkyKnight“), Dragoneer Investment Group („Dragoneer“) und Aquiline Capital Partners LLC („Aquiline“ und zusammen mit SkyKnight und Dragoneer „die Investoren“)...

ANN ARBOR, Mich., June 12, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today confirms it has received notice that the Institute of Clinical and Economic Review (ICER) plans to assess new non-statin medicines for hypercholesterolemia in the U.S., including the clinical cost effectiveness and value of NEXLETOL.  A report completion is targeted for February 2021.  ICER generally only assesses medicines that are expected to have a meaningful impact in a therapeutic area.  Esperion anticipates the assessment will find the same conclusions as the extensive pricing and value work already completed and the broad and high-quality managed care coverage already achieved for NEXLETOL.Driven by its mission of Lipid Management for Everybody, a core tenant of Esperion is to provide medicines that are both accessible and affordable to patients....

Poster presentation highlights Phase 1 clinical trial data demonstrating tolerability, pharmacokinetics and pharmacodynamics of KER-050 in healthy postmenopausal women.Poster presentations introduce data demonstrating KER-050 robustly promoted hematopoiesis in multiple animal species in preclinical studies and support a potentially novel mechanism of action.Oral presentation on a novel ALK2 kinase inhibitor that suppressed hepcidin production and subsequently ameliorated anemia in a mouse model of iron-refractory iron deficiency anemia.LEXINGTON, Mass., June 12, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with...